A carregar...
IMMU-23. CLINICAL AND IMMUNOLOGICAL CHARACTERIZATION OF IMMUNE CHECKPOINT MOLECULE LIGHT IN HUMAN GLIOMAS
BACKGROUND: Dysregulation of immune checkpoint molecules leads to immune evasion in human tumors but has become a viable target for tumor therapy. Here, we examined expression of LIGHT (TNFSF14), an immune checkpoint molecule, in human glioblastoma (GBM) to assess its potential as a molecular target...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7651746/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.453 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|